COLL logo

Collegium Pharmaceutical, Inc. (COLL) Cash From Operations

Annual CFO:

$204.98M-$69.77M(-25.39%)
December 31, 2024

Summary

  • As of today, COLL annual cash from operations is $204.98 million, with the most recent change of -$69.77 million (-25.39%) on December 31, 2024.
  • During the last 3 years, COLL annual cash from operations has risen by +$101.42 million (+97.94%).
  • COLL annual cash from operations is now -25.39% below its all-time high of $274.75 million, reached on December 31, 2023.

Performance

COLL Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLcash flow metrics

Quarterly CFO:

$78.44M+$6.00M(+8.28%)
September 30, 2025

Summary

  • As of today, COLL quarterly cash from operations is $78.44 million, with the most recent change of +$6.00 million (+8.28%) on September 30, 2025.
  • Over the past year, COLL quarterly cash from operations has increased by +$87.44 million (+971.63%).
  • COLL quarterly cash from operations is now -21.34% below its all-time high of $99.72 million, reached on June 30, 2023.

Performance

COLL Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLcash flow metrics

TTM CFO:

$290.92M+$87.44M(+42.97%)
September 30, 2025

Summary

  • As of today, COLL TTM cash from operations is $290.92 million, with the most recent change of +$87.44 million (+42.97%) on September 30, 2025.
  • Over the past year, COLL TTM cash from operations has increased by +$97.25 million (+50.21%).
  • COLL TTM cash from operations is now -5.86% below its all-time high of $309.01 million, reached on March 31, 2024.

Performance

COLL TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

COLL Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-25.4%+971.6%+50.2%
3Y3 Years+97.9%+83.4%+209.2%
5Y5 Years+637.8%+129.5%+234.3%

COLL Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-25.4%+97.9%-21.3%+971.6%-5.9%+209.2%
5Y5-Year-25.4%+637.8%-21.3%+409.9%-5.9%+404.4%
All-TimeAll-Time-25.4%+373.1%-21.3%+409.9%-5.9%+433.5%

COLL Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$78.44M(+8.3%)
$290.92M(+43.0%)
Jun 2025
-
$72.44M(+30.8%)
$203.48M(+2.5%)
Mar 2025
-
$55.40M(-34.6%)
$198.44M(-3.2%)
Dec 2024
$204.98M(-25.4%)
$84.64M(+1040.6%)
$204.98M(+5.8%)
Sep 2024
-
-$9.00M(-113.4%)
$193.67M(-30.0%)
Jun 2024
-
$67.40M(+8.8%)
$276.69M(-10.5%)
Mar 2024
-
$61.94M(-15.5%)
$309.01M(+12.5%)
Dec 2023
$274.75M(+121.2%)
$73.34M(-0.9%)
$274.75M(+2.6%)
Sep 2023
-
$74.02M(-25.8%)
$267.74M(+13.2%)
Jun 2023
-
$99.72M(+260.4%)
$236.49M(+33.4%)
Mar 2023
-
$27.67M(-58.3%)
$177.22M(+42.7%)
Dec 2022
$124.23M(+20.0%)
$66.33M(+55.1%)
$124.23M(+32.0%)
Sep 2022
-
$42.77M(+5.7%)
$94.10M(+37.2%)
Jun 2022
-
$40.45M(+259.8%)
$68.59M(+18.9%)
Mar 2022
-
-$25.32M(-169.9%)
$57.67M(-44.3%)
Dec 2021
$103.56M(+10.2%)
$36.20M(+109.8%)
$103.56M(+15.1%)
Sep 2021
-
$17.25M(-41.6%)
$89.94M(-15.8%)
Jun 2021
-
$29.54M(+43.6%)
$106.86M(-11.8%)
Mar 2021
-
$20.57M(-8.9%)
$121.18M(+29.0%)
Dec 2020
$93.94M(+238.1%)
$22.58M(-33.9%)
$93.94M(+8.0%)
Sep 2020
-
$34.18M(-22.1%)
$87.02M(+47.7%)
Jun 2020
-
$43.85M(+757.6%)
$58.91M(+98.5%)
Mar 2020
-
-$6.67M(-142.6%)
$29.68M(+6.8%)
Dec 2019
$27.78M
$15.66M(+158.0%)
$27.78M(-48.9%)
DateAnnualQuarterlyTTM
Sep 2019
-
$6.07M(-58.5%)
$54.41M(-39.7%)
Jun 2019
-
$14.63M(+270.7%)
$90.18M(-31.2%)
Mar 2019
-
-$8.57M(-120.3%)
$131.16M(-22.6%)
Dec 2018
$169.39M(+352.8%)
$42.29M(+1.1%)
$169.39M(+48.8%)
Sep 2018
-
$41.83M(-24.8%)
$113.81M(+91.6%)
Jun 2018
-
$55.60M(+87.5%)
$59.41M(+534.7%)
Mar 2018
-
$29.66M(+323.1%)
-$13.67M(+79.6%)
Dec 2017
-$67.02M(+10.7%)
-$13.30M(-5.8%)
-$67.02M(+13.0%)
Sep 2017
-
-$12.57M(+28.1%)
-$77.01M(+8.2%)
Jun 2017
-
-$17.47M(+26.3%)
-$83.86M(+3.9%)
Mar 2017
-
-$23.69M(-1.7%)
-$87.22M(-16.2%)
Dec 2016
-$75.05M(-248.0%)
-$23.29M(-19.9%)
-$75.05M(-28.6%)
Sep 2016
-
-$19.41M(+6.8%)
-$58.37M(-28.3%)
Jun 2016
-
-$20.84M(-80.9%)
-$45.49M(-56.5%)
Mar 2016
-
-$11.52M(-74.4%)
-$29.07M(-34.8%)
Dec 2015
-$21.57M(-20.2%)
-$6.60M(-1.0%)
-$21.57M(+4.3%)
Sep 2015
-
-$6.54M(-48.2%)
-$22.53M(-10.4%)
Jun 2015
-
-$4.41M(-9.8%)
-$20.40M(-12.1%)
Mar 2015
-
-$4.02M(+46.9%)
-$18.19M(-1.4%)
Dec 2014
-$17.95M(-8.6%)
-$7.57M(-71.7%)
-$17.95M(-72.9%)
Sep 2014
-
-$4.41M(-100.3%)
-$10.38M(-73.8%)
Jun 2014
-
-$2.20M(+41.6%)
-$5.97M(-58.4%)
Mar 2014
-
-$3.77M
-$3.77M
Dec 2013
-$16.53M
-
-

FAQ

  • What is Collegium Pharmaceutical, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. annual cash from operations year-on-year change?
  • What is Collegium Pharmaceutical, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. quarterly cash from operations year-on-year change?
  • What is Collegium Pharmaceutical, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. TTM cash from operations year-on-year change?

What is Collegium Pharmaceutical, Inc. annual cash from operations?

The current annual cash from operations of COLL is $204.98M

What is the all-time high annual cash from operations for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high annual cash from operations is $274.75M

What is Collegium Pharmaceutical, Inc. annual cash from operations year-on-year change?

Over the past year, COLL annual cash from operations has changed by -$69.77M (-25.39%)

What is Collegium Pharmaceutical, Inc. quarterly cash from operations?

The current quarterly cash from operations of COLL is $78.44M

What is the all-time high quarterly cash from operations for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high quarterly cash from operations is $99.72M

What is Collegium Pharmaceutical, Inc. quarterly cash from operations year-on-year change?

Over the past year, COLL quarterly cash from operations has changed by +$87.44M (+971.63%)

What is Collegium Pharmaceutical, Inc. TTM cash from operations?

The current TTM cash from operations of COLL is $290.92M

What is the all-time high TTM cash from operations for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high TTM cash from operations is $309.01M

What is Collegium Pharmaceutical, Inc. TTM cash from operations year-on-year change?

Over the past year, COLL TTM cash from operations has changed by +$97.25M (+50.21%)
On this page